TNF and rheumatoid arthritis: Although the introduction of anti-tumor necrosis factor (TNF) therapy and other new biologicals has played a major role in improving patient outcomes, RA is still associated with long-term morbidity and early mortality [3] Thus, there is still a need for the identification of new pathways involved in the modulation of inflammation, which could help to increase the efficacy of the RA treatment.